Skip to main content

Table 5 The outcome of patients with GTN

From: Comparison of different therapeutic strategies for complete hydatidiform mole in women at least 40 years old: a retrospective cohort study

Group of patients with GTN Time to GTN diagnosis (day) No. of courses of chemotherapy to cure Chemotherapy resistance Time for hCG to remission (day) Follow-up
Group I (n = 46) 54.0 ± 38.5 3.2 ± 1.9 23.7%(9/38) 59.6 ± 26.4 46 remission, 1 recurred 4 years later and died of brain metastasis
Group II (n = 5) 94.6 ± 35.9* 4.2 ± 2.4 80.0%(4/5)** 60.4 ± 18.6 5 remission,0 death
Group III (n = 4) 60.7 ± 43.0 2.7 ± 1.5 25.0%(1/4) 52.0 ± 23.3 4 remission,0 death
  1. * P = 0.031, compared to Group I; ** P = 0.024 compared to Group I
  2. Risk factors such as pre-evacuation hCG level, a theca luteal cyst over 6 cm and an enlarged uterus over presentation date and prognostic scores were evaluated among groups and no statistically significances were found